To further explore the clinical relevance, we collected tumor (T) tissues and paracancerous (P) normal tissues from patients with TNBC (n=5), HER2+ breast cancer (n=5), and HR+ breast cancer (n=5). This evidence concerns the gene ERBB2 and breast carcinoma.